The NANOPULSE‑AF study is evaluating the CellFX nano‑second pulsed field ablation (nsPFA) Cardiac Catheter System in people with drug‑resistant, symptomatic paroxysmal atrial fibrillation. The trial…
July 29, 2026
The NANOPULSE‑AF study is evaluating the CellFX nano‑second pulsed field ablation (nsPFA) Cardiac Catheter System in people with drug‑resistant, symptomatic paroxysmal atrial fibrillation. The trial…
Soluna Holdings’ (NASDAQ: SLNH) is enjoying a strong bounce today, with shares up roughly 23% and pushing further into the low‑$1 range. This move extends the…